Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...

Out of the 386 regencies and mayoralties targeted by the Health Ministry, fewer than half are estimated to have public health ...

Diego Cardeñosa always knew he wanted to study sharks. But when he started his Ph.D., he had to make a choice: tagging sharks ...

Precise tumor diagnosis and treatment require the support of abundant molecular information. However, conventional molecular ...

Early and sustained ctDNA clearance in early breast cancer treated with neoadjuvant HER2-targeted therapy tracks closely with pathologic complete response to treatment and 3-year outcomes.

CAAR ruled that multi-functional PCR instruments cannot be treated as spectrometers where optical detection is only one part ...

A landmark study, titled “How error correction affects polymerase chain reaction deduplication: A survey based on unique molecular identifier datasets of short reads” recently published in ...

KABUL (Pajhwok): A laboratory has been constructed and equipped with various advanced medical instruments, diagnostic materials, tables and chairs at a cost of 35 million afghanis at the Afghan ...

(WBL), a leader in native, long-read sequencing and epigenomic analysis, today announced a co-marketing agreement with Agilent Technologies to support the adoption of its Direct Targeted Methylation ...

Phoenix, Ariz, December 11th, 2025, FinanceWireWith periodontal disease affecting more than four in ten American adults and ...

York-based biotech firm Aptamer Group has announced a licensing agreement with synthetic biology and genomics company Twist ...

Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular ...